A detailed history of Gamma Investing LLC transactions in Inventiva S.A. stock. As of the latest transaction made, Gamma Investing LLC holds 1,780 shares of IVA stock, worth $7,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,780
Holding current value
$7,048
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 02, 2026

BUY
$3.68 - $6.9 $6,550 - $12,282
1,780 New
1,780 $8.28 Million

Others Institutions Holding IVA

About Inventiva S.A.


  • Ticker IVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,134,200
  • Market Cap $167M
  • Description
  • Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...
More about IVA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.